Case Study:
Automated change requests in dossiers
using LLMs and NLP
How AI is helping regulatory teams increase productivity and reduce guidance monitoring time
The Client
The client was spending significant time keeping up to date with monitoring and evaluating new guidances from WHO and others depending on the countries. This was a very resource-intense activity and they wanted a way to automate part of this so that the human in the loop could check it but not do the time-consuming work of actually looking everything up and reconciling the documents.
The Solution
- Combining the use of a specifically-trained LLM (large language model) and another semantic NLP approach to understand text in guidance and identify within guidance documents what text must be changed in the dossier.
- Classifying change level (minor, medium, major and implementing and highlighting the changes in both documents for approval.
The Outcome
- Saves regulatory team vast amounts of time as previously each new guidance had to be read and compared with the dossier but now the changes are classified and suggestions created and the regulatory person simply needs to check these and approve.
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
We’re Doing AI” Is Not a Board Answer
There is a moment I have seen play out in pharmaceutical boardrooms again and again. It usually comes in the second half of the agenda,
Why Most AI Governance Frameworks Are the Wrong Fit for Pharma
Most pharmaceutical organizations now have some form of AI governance. On paper, that sounds reassuring. In practice, it often means a policy document, a review
Why Most Pharma AI Strategies Fail the CFO Test
Most pharmaceutical organizations do not struggle to explain what their AI programmes do. They struggle to explain, in financial terms, why those programmes deserve sustained